Amarin Corp Plc (AMRN)

[Biobillionair]

DMEC - Mary Parks....No

Next
Office of Drug Evaluation II (ODE II)
Director: Curtis J. Rosebraugh, M.D., M.P.H.

Then
Office of New Drugs
John Jenkins, M.D., Director

Then
CDER Director
Janet Woodcock, M.D?

Then
Dr. Hamburg

Then
Kathleen Sebelius

As a note to the directors, 3 high ranking officials have lost their jobs already due to Congressional & Investor pressures and accusations of regulatory "accidents".

However, EPAdrugintiave (wish we picked a shorter name now;) CP due 180 days and responses requested from Commish